What is Severe Persistent Asthma? What is Bronchial Thermoplasty Non pharmacologic treatment of asthma

Similar documents
Complements asthma therapy NOT a CURE for Severe. Non pharmacologic treatment of asthma. limits the ability of the airways to constrict.

Bronchial Thermoplasty For Severe Persistent Asthma

Endobronchial Thermoplasty

Endobronchial Thermoplasty

Robert Kruklitis, MD, PhD Chief, Pulmonary Medicine Lehigh Valley Health Network

Smooth Muscle & Asthma: Bronchial Thermoplasty - A Smooth Muscle Modifier

Corporate Medical Policy

The New Medtech Economic Reality MassMEDIC Annual Meeting

THE PROMISE OF NEW AND NOVEL DRUGS. Pyng Lee Respiratory & Critical Care Medicine National University Hospital

BRONCHIAL THERMOPLASTY

Bronchial Thermoplasty

HCT Medical Policy. Bronchial Thermoplasty. Policy # HCT113 Current Effective Date: 05/24/2016. Policy Statement. Overview

Interventional Pulmonology

West of Scotland Difficult Asthma Group Statement of Practice

Subject: Bronchial Thermoplasty

BRONCHIAL THERMOPLASTY

BRONCHIAL THERMOPLASTY

Running Head: THE PRACTICALITY OF BRONCHIAL THERMOPLASTY 1. Review of a New Treatment for Severe Asthma: The Practicality of Bronchial Thermoplasty

Bronchial Thermoplasty

Five Consecutive cases of Bronchial Thermoplasty

Bronchial Thermoplasty

BRONCHIAL THERMOPLASTY

Clinical Policy Title: Bronchial thermoplasty for severe asthma

Asthma Management in Pregnancy HEATHER HOWE, MD UNIVERSITY OF UTAH PULMONARY DIVISION

Learning the Asthma Guidelines by Case Studies

Bronchial Thermoplasty

ASTHMA IN THE PEDIATRIC POPULATION

Asthma in Day to Day Practice

Medical Review Criteria Bronchial Thermoplasty

WEBINAR. Difficult-to-treat and severe asthma: changing the paradigm

This is a cross-sectional analysis of the National Health and Nutrition Examination

Endobronchial thermoplasty for asthma

Introduction to Interventional Pulmonology

BRONCHIAL THERMOPLASTY

Global Initiative for Asthma (GINA) What s new in GINA 2016?

New Therapies for Asthma

Adult asthma management: focus on control

Case-Compare Impact Report

Asthma Management for the Athlete

Biologic Therapy in the Management of Asthma. Nabeel Farooqui, MD

PFT s / 2017 Pulmonary Update. Eric S. Papierniak, DO University of Florida NF/SG VHA

Clinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy

Meeting the Challenges of Asthma

Symptoms are worse at night and in the morning and includes cough, whz, chest tightness.

Asthma Treatment Update: 2018

Tips on managing asthma in children

Evaluation and Management of Refractory Asthma

ASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009

Asthma Care in the Emergency Department Clinical Practice Guideline

Methacholine versus Mannitol Challenge in the Evaluation of Asthma Clinical applications of methacholine and mannitol challenges

Asthma in the Athlete

Clinical Policy Title: Bronchial thermoplasty for severe asthma

Exercise-Induced Bronchospasm. Michael A Lucia, MD, FCCP Asst Clinical Professor, UNR School of Medicine Sierra Pulmonary & Sleep Institute

Outline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?

Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing

Clinical Practice Guideline: Asthma

Asthma Upate 2018: What s New Since the 2007 Asthma Guidelines of NAEPP?

Asthma Update A/Prof. John Abisheganaden. Senior Consultant, Dept Of Respiratory & Crit Care Medicine Tan Tock Seng Hospital

Decramer 2014 a &b [21]

12/18/2017. Disclosures. Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing

DR REBECCA THOMAS CONSULTANT RESPIRATORY PHYSICIAN YORK DISTRICT HOSPITAL

Knowledge is Power. Education- it s not for sissies!

Omalizumab (Xolair ) ( Genentech, Inc., Novartis Pharmaceuticals Corp.) September Indication

COPD: A Renewed Focus. Disclosures

Allergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma

Cigna Drug and Biologic Coverage Policy

ADULT ASTHMA GUIDE SUMMARY. This summary provides busy health professionals with key guidance for assessing and treating adult asthma.

LINEE GUIDA DELL ASMA: UP TO DATE

Phenotypes of asthma; implications for treatment. Medical Grand Rounds Feb 2018 Jim Martin MD DSc

Diagnosis, Treatment and Management of Asthma

TORCH: Salmeterol and Fluticasone Propionate and Survival in COPD

Community COPD Service Protocol

Greater Manchester Asthma Management Plan 2018 Inhaler therapy options for adult patients (18 and over) with asthma

On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children

UPDATE ON ASTHMA MEDICATIONS INCLUDING BIOLOGICS FOR SEVERE PERSISTENT ASTHMA JOAN O LEAR FNP AE- C KENWOOD ALLERGY AND ASTHMA CENTER

Usefulness of Bronchial Thermoplasty for Patients with a Deteriorating Lung Function

Pharmacological Management of Obstructive Airways in Humans. Introduction to Scientific Research. Submitted: 12/4/08

Air Flow Limitation. In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation.

Bronchial Thermoplasty for the Treatment of Severe Asthma

Controversial Issues in the Management of Childhood Asthma: Insights from NIH Asthma Network Studies

Learning Objective. Asthma. Discuss the pathophysiology, clinical presentation, diagnosis, and treatment of Asthma 2/22/2017

Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit)

Provider Respiratory Inservice

Nancy Davis, RRT, AE-C

Getting Asthma treatment right. Dr David Cremonesini Specialist Pediatrician American Hospital

Asthma: Chronic Management. Yung-Yang Liu, MD Attending physician, Chest Department Taipei Veterans General Hospital April 26, 2015

Prof Neil Barnes. Respiratory and General Medicine London Chest Hospital and The Royal London Hospital

Meenu Singh, Joseph L. Mathew, Prabhjot Malhi, B.R. Srinivas and Lata Kumar

2. Does the patient have chronic urticaria? Y N

Starship Paediatric Respiratory and Sleep Medicine Department Outpatient Referral Criteria General Principles

MAYA RAMAGOPAL M.D. DIVISION OF PULMONOLOGY & CYSTIC FIBROSIS CENTER

Systems Pharmacology Respiratory Pharmacology. Lecture series : General outline

SYNOPSIS A two-stage randomized, open-label, parallel group, phase III, multicenter, 7-month study to assess the efficacy and safety of SYMBICORT

Key features and changes to these four components of asthma care include:

Amanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ

History & Development

Learning Objectives. Updates in Interventional Pulmonary Medicine. Brief History of IP. Brief History of IP. Who is an Interventional Pulmonologist?

Updates in Interventional Pulmonary Medicine

GINA. At-A-Glance Asthma Management Reference. for adults, adolescents and children 6 11 years. Updated 2017

Asthma. Definition. Symptoms

Transcription:

Objectives BT defined What is Severe Persistent Asthma Case Study introduction How is BT performed Pre-op, PACU and Discharge care Who does it work for the criteria for BT Brief overview of BT results Case Study completion Summary Bronchial Thermoplasty Karla Provost Pulmonary and Critical Care Medicine 2015 What is Severe Persistent Asthma? What is Bronchial Thermoplasty Non pharmacologic treatment of asthma ERS/ATS 2014 Guidelines: Severe asthma is defined as Outpatient procedure performed over 3 treatment sessions by a trained physician asthma which requires treatment with high dose inhaled corticosteroids (ICS) plus a second controller (and/or systemic corticosteroids) to prevent it from becoming uncontrolled or which remains uncontrolled despite this therapy. 1 Delivers thermal energy to the airways via a bronchoscope to reduce airway smooth muscle limits the ability of the airways to constrict. Complements asthma therapy NOT a CURE for Severe Asthma 5%-10% of total asthma population estimated to have severe asthma1 increase the level of asthma control and improve quality of life ERS = European Respiratory Society ATS = American Thoracic Society 1. Chung KF, et al. Eur Respir J. 2014 Feb;43(2):343-73. 4 Higher Cost of Severe Asthma (U.S.) Airway smooth muscle constriction during an asthma attack Higher healthcare costs with asthma severity2 Cost/Patient/Year $12,000 Est. $56B total cost of asthma1 Emergency Room (ER) visits Hospitalizations $8,000 Patients with exacerbations have higher health care costs than patients without exacerbations3 $6,000 $2,000 Asthmatic Airway Asthma Attack 5 Ref: ENDO-15402-AB Increased healthcare utilization $10,000 $4,000 Normal Airway $12,800 $4,800 $2,200 Mild Moderate Severe 1. Barnett SBL, et al. Costs of asthma in the United States: 2002 2007. J Allergy Clin Immunol 2011;127:145 52. 2. Cisternas M, et al., A comprehensive study of the direct and indirect costs of an adult with asthma. J Allergy Clin Immunol 2003;111(6):1212-1218. 3. American Lung Association, Trends in Asthma Morbidity and Mortality, February 2010 report. 6

Overall: Severe Persistent Asthma Can have normal spirometry Using high dose ICS + additional controlling medication Limited by symptoms despite therapy. Frequent use of prednisone Frequents the UC/ER, doctors visits. Consider BT. Case Study (BT) 8 BT girl 20 y/o F Asthma since birth, aspirated meconium Nasal polyps, ASA sensitivity For the last 6 months has had 3 flares of asthma requiring prednisone. Current meds: Singulair, BID Claritin, BID Flonase, PPI. Dulera 200 2 puffs BID, Albuterol nebs and short acting inhaler BT girl Using albuterol inhaler 2-3 times per day, anytime she ambulates, 2-3 times per night. Prednisone tapers monthly for the last 4 months Gained 50 lbs. in the last 6 months. Never been able to run, afraid to be alone due to asthma symptoms, mobility limited due to SOB. Referred to you for further asthma management. BT Reduces Excess Airway Smooth Muscle (ASM) How is Bronchial Thermoplasty performed? 1 Reduce Airway Smooth Muscle (ASM) Reduce Bronchoconstriction Reduce Asthma Exacerbations Improve Asthma Quality of Life 1. Woodruff PG, et al. Am J Respir Crit Care Med. 2004;169:1001-1006. 12

The Alair System BT, Delivered by the Alair System Alair Catheter a flexible tube with an expandable wire array at the tip to deliver therapeutic RF energy to the airway walls via a standard bronchoscope Alair Radiofrequency (RF) Controller designed to safely and accurately deliver precise, controlled RF energy through the Catheter to the airway walls 13 14 BT Completed in 3 Outpatient Procedures The Catheter Does it get hot? No It uses impedance of the radio waves (RFA) at the level of the smooth muscle and creates heat only at the muscle level. Catheter itself heats to 65C 149F for 10 seconds OR 120 joules which ever comes first. BT is performed by a BT-certified pulmonologist in 3 outpatient visits, typically scheduled 3 weeks apart. 15 How it is performed at Essentia Consult with all candidates/referrals in pulmonary outpatient office prior to approval. Evaluated for Asthma and other diagnoses. Labs, CXR, PFTs, record review, history. If meets all criteria then await insurance approval. Adverse events: Asthma exacerbation/wheezing Sore throat Atelectasis Hemoptysis Respiratory tract infection

Pre-procedure All patients receive prophylactic prednisone (50mg/day) for 5 days (3 days before, day of, and day after procedure) Pre-op, PACU and Discharge care 19 20 Procedure Overview Pre-op/day of procedure- Activate anesthesia order set: Vitals, saline lock, cath, pulse ox, etc... Lung function 80% of known outpatient baseline FEV¹ values. OR General Anesthesia- OR RN or tech perform airway mapping documentation Diagnostic Bronch ~ 1 hr. Extubated post procedure and sent to PACU PACU- Patient monitored 2-4 hrs. post-op and discharge home same day Post-Procedure/Patient Follow Up Patient contacted via phone at 1, 2 and 7 days to assess post procedure status Office visit at 4 weeks to assess clinical stability and schedule subsequent BT procedures as appropriate After BT treatment, patient returns to primary asthma physician for ongoing asthma management Patient evaluated for step-down therapy to determine lowest level of medication necessary to maintain asthma control Lung function stable 80% of pre-procedure post-bd FEV¹ 21 22 Who qualifies for BT? Who are the Right Patients for BT? Who qualifies for BT? Patients with: Diagnosed severe persistent asthma 18 years and older Not well controlled with adherence to inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) Two or more severe exacerbations in the prior year Impaired quality of life Despite Anti IgE, Immunotherapy <10 pack year smoking history, non smoker for at least 1 year. 23

Contraindications Contraindications BT should not be performed on: Patients that have a pacemaker, defibrillator, or other implantable electronic device Patients that have a known sensitivity to medications required to perform bronchoscopy, including lidocaine, atropine, and benzodiazepines Documented COPD/emphysema Patients that have previously been treated with the Alair System BT should be delayed for the following: Active respiratory infection Asthma attack or changing dose of systemic corticosteroids (up or down) in the past 14 days Known bleeding disorder Patient is unable to stop taking anticoagulants, antiplatelet agents, aspirin or non-steroidal anti-inflammatory medications (NSAIDS) before the procedure with physician guidance Reference the Alair Bronchial Thermoplasty System Directions for Use for more information. Reference the Alair Bronchial Thermoplasty System Directions for Use for more information. 25 26 High Patient Satisfaction with BT 97% of BT patients would probably or definitely recommend BT to a friend or family member. 1 Overall - Proven clinical benefits In a clinical study of patients with severe asthma, patients treated with BT experienced: 32% decrease in severe asthma attacks 1 84% reduction in asthma-related emergency room visits 1 66% fewer days lost from work, school, and daily activities due to asthma 1 Additionally: 79% of patients treated with BT saw a significant improvement in their asthma-related quality of life. 1 Maintained effects at 5 years. 1. Data on file. Reported at 1 year follow-up. 28 27 1. Castro, Am J Respir Crit Care Med. 2010;181(2):116-24. Ref: ENDO-144502-AA Summary: Definition of BT and Severe Persistent Asthma What is BT How is it performed 3 sessions, outpatient Criteria to qualify, contraindications, adverse events Clinical trial results Decreased ER/UC visit, improved quality of life, less prednisone usage over a year, less days lost from school/work. 350 Domestic US BT Centers 12/2014

Back to our patient We tried multiple additional inhalers all with side effects She started receiving allergy shots, was not a candidate for Xolair therapy. Underwent bronchial thermoplasty Now on allergy controllers, moderate ICS Ran a 5K for the first time in her life this summer. Lost 60 lbs. since BT Here with you http://www.wdio.com/article/stories/s3608951.shtml Questions?